Identifier |
20080310_nanos_sciplatform_05.pdf |
Title |
Orally Administered SIRTl Activator SRT501 is Neuroprotective for Retinal Ganglion Cells and Suppresses Neurological Dysfunction in a Mouse Model of Multiple Sclerosis |
Creator |
Kenneth S. Shindler; Elvira Ventura; Peter Elliott; A.M. Rostami |
Affiliation |
(KSS) University of Pennsylvania, Philadelphia, PA; (EV) (AMR) Thomas Jefferson University Philadelphia, PA; (PE) Sirtris Pharmaceuticals, Cambridge, MA |
Subject |
Optic Neuritis; Neuroprotection; Retinal Ganglion Cells; Multiple Sclerosis; EAE |
Description |
Neuronal loss in multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE), correlates with permanent neurological dysfunction. Intravitreal injection of compounds that activate SIRTl, an NAD+-dependent deacetylase involved in cellular stress resistance and survival, attenuates retinal ganglion cell (RGC) loss during acute optic neuritis in EAE mice. |
Date |
2008-03-10 |
Language |
eng |
Format |
application/pdf |
Type |
Text |
Source |
2008 North American Neuro-Ophthalmology Society Annual Meeting |
Relation is Part of |
NANOS 2008: Platform Session I |
Collection |
Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/ |
Publisher |
North American Neuro-Ophthalmology Society |
Holding Institution |
Spencer S. Eccles Health Sciences Library, University of Utah |
Rights Management |
Copyright 2010. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
ARK |
ark:/87278/s6dr61t8 |
Setname |
ehsl_novel_nam |
ID |
180792 |
Reference URL |
https://collections.lib.utah.edu/ark:/87278/s6dr61t8 |